Abemaciclib plus fulvestrant in East Asian women with HR+, HER2− advanced breast cancer: Overall survival from MONARCH 2
Toi, Masakazu, Huang, Chiun‐Sheng, Im, Young‐Hyuck, Sohn, Joohyuk, Zhang, Wei, Sakaguchi, Sachi, Haddad, Nadine, Hal, Gertjan, Sledge, George W.
Published in Cancer science (01.01.2023)
Published in Cancer science (01.01.2023)
Get full text
Journal Article
Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Protein Kinase C β-Inhibitor Enzastaurin in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer
RADEMAKER-LAKHAI, Jeany M, BEEREPOOT, Laurens V, VAN HAL, Gertjan, BEIJNEN, Jos H, SCHELLENS, Jan H. M, VOEST, Emile E, MEHRA, Niven, RADEMA, Sandra A, VAN MAANEN, Rianne, VERMAAT, Joost S, WITTEVEEN, Els O, VISSEREN-GRUL, Carla M, MUSIB, Luna, ENAS, Nathan
Published in Clinical cancer research (01.08.2007)
Published in Clinical cancer research (01.08.2007)
Get full text
Journal Article
A randomized, open-label, phase 2 study evaluating abemaciclib in combination with irinotecan and temozolomide in participants with relapsed or refractory Ewing sarcoma
VAN HAL, Gertjan, Rubio-San-Simón, Alba, Ogawa, Chitose, Juan-Ribelles, Antonio, Knoderer, Holly, Lewin, Jeremy Howard
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Abstract P1-18-21: Abemaciclib plus fulvestrant or nonsteroidal aromatase inhibitor in participants with HR+, HER2- breast cancer - A pooled analysis of the endocrine therapy-naïve participants with measurable disease in MONARCH 2 and MONARCH 3
Goetz, Matthew P., Trujillo, Jose Luis Gonzalez, Toi, Masakazu, Huober, Jens, Llombart-Cussac, Antonio, Zhang, Wei, Knoderer, Holly, Haddad, Nadine, Van Hal, Gertjan, Sledge, George W.
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer
Lim, Elgene, Boyle, Frances, Okera, Meena, Loi, Sherene, Goksu, Sema Sezgin, van Hal, Gertjan, Chapman, Sonya C., Gable, Jonathon Colby, Chen, Yanyun, Price, Gregory L., Hossain, Anwar M., Gainford, M. Corona, Ezquerra, Meritxell Bellet
Published in Breast cancer research and treatment (01.10.2022)
Published in Breast cancer research and treatment (01.10.2022)
Get full text
Journal Article
Abstract P5-14-05: The impact of food on tolerability of abemaciclib in patients with previously treated hormone receptor-positive, HER2-negative, metastatic breast cancer: An open-label, randomized phase 2 study
Lim, Elgene, Boyle, Frances, Okera, Meena, Loi, Sherene, Goksu, Sema Sezgin, van Hal, Gertjan, Hartman, Daisy G, Gable, Jonathon Colby, Price, Gregory L, Hossain, Anwar, Gainford, M C, Ezquerra, Meritxell Bellet
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
Abstract PD13-11: PD13-11 Final Overall Survival Analysis of Monarch 2 : A Phase 3 trial of Abemaciclib Plus Fulvestrant in Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Llombart-Cussac, Antonio, Sledge, George, Toi, Masakazu, Neven, Patrick, Sohn, Joo Hyuk, Inoue, Kenichi, Pivot, Xavier, Okera, Meena, Masuda, Norikazu, Kaufman, Peter A., Koh, Han, Grischke, Eva-Maria, Conte, PierFranco, Andre, Valerie, Bian, Yuanyuan, Shahir, Ashwin, van Hal, Gertjan
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract GS01-12: MONARCH 3: Final overall survival results of abemaciclib plus a nonsteroidal aromatase inhibitor as first-line therapy for HR+, HER2- advanced breast cancer
Goetz, Matthew, Toi, Masakazu, Huober, Jens, Sohn, Joo Hyuk, Trédan, Olivier, Park, Inhae, Campone, Mario, Chen, Shin-Cheh, Manso, Luis Manual, Paluch-Shimon, Shani, Freedman, Orit C., Andre, Valerie, Saha, Abhijoy, van Hal, Gertjan, Shahir, Ashwin, Iwata, Hiroji, Johnston, Stephen RD, O'Shaughnessy, Joyce, Pivot, Xavier, Tolaney, Sara, Hurvitz, Sara, Llombart, Antonio
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Protein Kinase C {szligbeta}-Inhibitor Enzastaurin in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer
Rademaker-Lakhai, Jeany M, Beerepoot, Laurens V, Mehra, Niven, Radema, Sandra A, van Maanen, Rianne, Vermaat, Joost S, Witteveen, Els O, Visseren-Grul, Carla M, Musib, Luna, Enas, Nathan, van Hal, Gertjan, Beijnen, Jos H, Schellens, Jan HM, Voest, Emile E
Published in Clinical cancer research (01.08.2007)
Get full text
Published in Clinical cancer research (01.08.2007)
Journal Article